Arne Klungland, Ph.D.
Professor and Director
Institute of Medical Microbiology, BIG CAS-OSLO Genome Research Cooperation, Oslo University Hospital, Rikshospitalet,
The title of the lecture:
Reversible modifications on proteins and RNA; role in development and cancer
Arne Klungland received his master degree in genetics at the University of Oslo in 1988 and went on to do a PhD at the Norwegian Defense Research Establishment in 1994. After receiving his PhD he worked 5 years as a post doc under the supervision of Tomas Lindahl at Imperial Cancer Research Fund, Clare Hall, London UK. In 2000 he was a guest researcher at IGBMC, Strasbourg. He then joined the Oslo University Hospital where he today is a professor and research director at Department for Molecular Medicine.
Throughout his career he has focused on dynamic modifications in DNA, RNA and Proteins. During his PhD and Post Doc he focused on DNA repair. Recently, this focus has been “modified” to regulatory modifications. His research is currently supported by the research council of Norway, The Norwegian Cancer Society, EU and Oslo University and Oslo University Hospital.
In recent years, his major finding is a novel reversible modification on RNA. He is an author on 100 publications in biomedical journals including Molecular Cell, Nature, PNAS, Nature Chemical Biology, Nature Communications, Journal of Clinical Investigation (JCI), EMBO J, PNAS, Molecular Cell Biology (MCB).
His four recent representative publications are: Chymkowitch et al, Genome Res. 25:897-906 (2015); Robertson et al. Nat Chem Biol.10:487-8, (2014); Li et al. Nature Comm 2013;4:1832; Sahu et al. Mol Cell. 10;49:18-29 (2013); Calvo et al. J Clin Invest. 122:2680-9 (2012).